Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies

Stopped early

Conditions studied: Cardiovascular Disease, Cerebrovascular Disorders

In brief

An observational safety follow up trial will be conducted to monitor the occurrence of cardiovascular events and all cause mortality in subjects who participated in selected torcetrapib/atorvastatin Phase 1, 2, and 3 clinical trials. No hypotheses will be tested.

Key facts

Study ID

NCT00452842

Run by

Pfizer

People needed

26784

Starts

2007-10-01

Last updated by the study team

2008-02-22

Who can join

Age: 10 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have signed informed consent prior to the initiation of any study-specific activities.
• Have participated in selected torcetrapib/atorvastatin Phase 1, 2, and 3 clinical trials and were treated with randomized study medication.

You may not qualify if…

• There are no exclusion criteria.

Where it is running

• Pfizer Investigational Site — Clearwater, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.